Peter Simonson, MD
Obstetrics & Gynecology · Suffern, NYNPI 1811973258
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,283 of the $2,972 with a category attached, or 76.8%. 26 manufacturers reported payments, led by AbbVie at 24.3% of the total. Reporting peaked in 2019 at $1,171 and has fallen 94.7% since, to $62 in 2025.
Across 125 payments — averaging $23.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$724
- Celularity Inc.$600
- Therapeuticsmd, Inc.$296
- Pfizer$246
- Exeltis, USA Inc.$216
- Astellas Pharma US Inc$195
- plus $696 from 20 others
What the payments were for
- Speaking & faculty fees$60020%
- Food & beverage$2,28377%
- Education$903%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $724 |
| Celularity Inc. | 2 | $600 |
| Therapeuticsmd, Inc. | 18 | $296 |
| Pfizer | 11 | $246 |
| Exeltis, USA Inc. | 12 | $216 |
| Astellas Pharma US Inc | 7 | $195 |
| Roche Diagnostics Corporation | 4 | $98 |
| Duchesnay USA Incorporated | 5 | $93 |
| Avion Pharmaceuticals | 5 | $72 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Hologic Sales And Service, LLC | 1 | $43 |
| Shield Therapeutics Inc | 1 | $41 |
| Millicent US Inc | 2 | $35 |
| Myovant Sciences Inc. | 2 | $33 |
| Medtronic | 1 | $33 |
| Agile Therapeutics, Inc. | 1 | $25 |
| Mycovia Pharmaceuticals, Inc. | 1 | $23 |
| Coopersurgical, Inc. | 1 | $23 |
| Organon | 2 | $22 |
| Evofem Biosciences, Inc. | 1 | $20 |
| Bayer | 1 | $18 |
| Exact Sciences | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Mayne Pharma Commercial LLC | 1 | $13 |
| Minerva Surgical, Inc | 1 | $13 |
How this compares
$2,972 in reported general payments places this provider in the 85th percentile of 2,673 obstetrics & gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 76 | $7,871 |
| Solifenacin Succinate | 24 | $1,676 |
| Clobetasol Propionate | 26 | $883 |
| Estradiol (Twice Weekly)Estradiol | 11 | $479 |
| Terconazole | 14 | $413 |
| ValacyclovirValacyclovir Hcl | 14 | $238 |
| Ketoconazole | 14 | $204 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 14 | $147 |
| Triamcinolone Acetonide | 27 | $113 |
| Fluconazole | 13 | $58 |
| ProgesteroneProgesterone, Micronized | 11 | $41 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Suffern
- Mary PolanNew York$862K
- Steven GoldsteinNew York$551K
- Veronica LernerNew York$368K
- Lisa EngNew York$219K
- Theodore GoldmanEast Northport$213K
- Miriam CremerBrooklyn$196K
- Rachel MaschNew York$187K
- Amy PollackNew York$184K
- Jian Qun HuangNew York$160K
- Carolyn WesthoffNew York$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.